Opening book details…
About this Medicine article
6617 POSTER Does the use of erlotinib for the treatment of relapsed stage IIIB/IV NSCLC patients improve quality-adjusted survival compared with docetaxel by Lewis, G.; Creeden, J.; Gyldmark, M. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Lewis, G.; Creeden, J.; Gyldmark, M.
- Publisher
- Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 1359-6349)
- Published
- 2007
- Language
- EN
- Field
- Medicine (Health Sciences)